Scientific Sessions 2024  /  Featured Science: Amyloid, Hypertrophic, and Danon Cardiomyopathies: Targeted Therapies and Specific Populations  /  Discussant: VALOR-HCM
Logo

American Heart Association

  143
  0

Final ID:

Discussant: VALOR-HCM

  • Deswal, Anita  ( Univ. of Texas MD Anderson Cancer Center , Bellaire , Texas , United States )
  • Ho, Jennifer  ( Harvard Medical School , Newton , Massachusetts , United States )
  • Ho, Carolyn  ( Carolyn Ho , Brookline , Massachusetts , United States )
  • Day, Sharlene  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
    • Author Disclosures:
    Anita Deswal: DO have relevant financial relationships ; Consultant:Bayer (Any division):Active (exists now) | Jennifer Ho: DO have relevant financial relationships ; Individual Stocks/Stock Options:Pfizer:Active (exists now) | Carolyn Ho: DO have relevant financial relationships ; Research Funding (PI or named investigator):Bristol Myers Squib:Active (exists now) ; Consultant:viz.ai:Active (exists now) ; Consultant:Lexicon:Active (exists now) ; Consultant:Tenaya:Active (exists now) ; Research Funding (PI or named investigator):Tenaya:Active (exists now) ; Consultant:Biomarin:Active (exists now) ; Research Funding (PI or named investigator):Biomarin:Active (exists now) ; Consultant:Cytokinetics:Active (exists now) ; Research Funding (PI or named investigator):Cytokinetics:Active (exists now) ; Consultant:Bristol Myers Squib:Active (exists now) | Sharlene Day: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Featured Science: Amyloid, Hypertrophic, and Danon Cardiomyopathies: Targeted Therapies and Specific Populations

Monday, 11/18/2024 , 09:45AM - 11:00AM

Featured Science

More abstracts on this topic:
Impact of vutrisiran on outpatient worsening heart failure in patients with transthyretin amyloidosis with cardiomyopathy in the HELIOS-B trial

Fontana Marianna, Maurer Mathew, Gillmore Julian, Bender Shaun, Aldinc Emre, Eraly Satish, Jay Patrick, Solomon Scott

Danon Disease Phase 1 RP-A501 Results: The First Single-Dose Intravenous Gene Therapy with Recombinant Adeno-Associated Virus (AAV9:LAMP2B) for a Monogenic Cardiomyopathy

Greenberg Barry, Coggins Matthew, Schwartz Jonathan, Rossano Joseph, Taylor Matthew, Colan Steven, Adler Eric, Ricks David, Yarabe Paul, Battiprolu Pavan, Shah Guarav, Patel Kinnari

More abstracts from these authors:
The Rings of Power: HFrEF Quadruple Therapy and AF

Bozkurt Biykem, Deswal Anita, Dunlay Shannon

Building Blocks: How To Build a Clinical Cardio-Oncology Program

Deswal Anita

You have to be authorized to contact abstract author. Please, Login
Not Available